Cross-docking and molecular dynamic studies to achieve the potent antiviral HIV-1 nonnucleoside reverse transcriptase inhibitors. Sci. Ess. J. 2023;39(2):23-37. Accessed October 23, 2026. https://ejournals.swu.ac.th/sej/article/view/15577